| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5630796 | POWDER PHARMS | Method of delivering powder transdermally with needless injector |
May, 2014
(9 years ago) | |
| US5899880 | POWDER PHARMS | Needleless syringe using supersonic gas flow for particle delivery |
May, 2016
(7 years ago) | |
| US6881200 | POWDER PHARMS | Needleless syringe using super sonic gas flow for particle delivery |
Jun, 2016
(7 years ago) | |
| US6004286 | POWDER PHARMS | Particle delivery |
Mar, 2017
(7 years ago) | |
| US8540665 | POWDER PHARMS | Particle cassettes and processes therefor |
Oct, 2029
(5 years from now) | |
| US9358338 | POWDER PHARMS | Particle cassettes and processes therefor |
Apr, 2035
(11 years from now) | |
| US9370622 | POWDER PHARMS | Devices and methods for delivering particles |
Sep, 2035
(11 years from now) | |
Zingo is owned by Powder Pharms.
Zingo contains Lidocaine Hydrochloride.
Zingo has a total of 7 drug patents out of which 4 drug patents have expired.
Expired drug patents of Zingo are:
- US5630796
- US5899880
- US6881200
- US6004286
Zingo was authorised for market use on 16 August, 2007.
Zingo is available in system;intradermal dosage forms.
Zingo can be used as zingo is a powder intradermal system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action, zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action.
The generics of Zingo are possible to be released after 28 September, 2035.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Jan 08, 2012 |
Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient
Market Authorisation Date: 16 August, 2007
Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intrader...
Dosage: SYSTEM;INTRADERMAL
ZINGO family patents
